Product Information
TOLVAPTAN 30 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $72.5518 per EA under NDC 31722086903. Its NADAC has been published 74 times since Jul 17, 2024.
FDA first approved this application on Jul 16, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722086903
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
12/18/2024
Active Ingredients
TOLVAPTANApproval Type
Generic (ANDA)
FDA Application
ANDA205646FDA Approved
7/16/2021
TE Code
AB1
On Market Since
7/16/2021
Pharmacological Classes
Price Statistics
The NADAC for TOLVAPTAN 30 MG TABLET has been published 74 times since Jul 17, 2024, and over the history we have for it it has risen 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $72.5518 per EA |
|---|---|
| All-time high | $72.5518 (Dec 10, 2025) |
| All-time low | $58.3386 (Jul 17, 2024) |
| 52-week high | $72.5518 |
| 52-week low | $72.5518 |
| Median price | $72.5518 |
| Average price | $69.8628 |
| Largest weekly change | +24.4% (Oct 23, 2024) |
| Weeks tracked | 74 |
| Tracking since | Jul 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
+24.4%
Last surveyed Dec 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOLVAPTAN 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOLVAPTAN 30 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $72.5518 per EA (NDC 31722086903), effective Dec 10, 2025.
How has the price of TOLVAPTAN 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOLVAPTAN 30 MG TABLET has risen 24.4%. It has been tracked across 74 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for TOLVAPTAN 30 MG TABLET?
Since Jul 17, 2024, the NADAC for TOLVAPTAN 30 MG TABLET has ranged from a low of $58.3386 (Jul 17, 2024) to a high of $72.5518 (Dec 10, 2025), with a median of $72.5518 per EA.
Are there cheaper alternatives to TOLVAPTAN 30 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOLVAPTAN 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TOLVAPTAN 30 MG TABLET?
TOLVAPTAN 30 MG TABLET (NDC 31722086903) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.